Innate Donor Effector Allogeneic Lymphocyte Infusion After Stem Cell Transplantation: the IDEAL Trial
Clinical trial NCT05686538 · RECRUITING
Trial details
- NCT number
- NCT05686538
- Sponsor
- Rigshospitalet, Denmark
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2028-01-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.